Clark County Disease Statistics* Fourth Quarter, 2016

 201420152016Rate(Cases per 100,000 per quarter)Quarterly Rate Comparison
DiseaseQ4
No.
YTD
No.
Q4
No.
YTD
No.
Q4
No.
YTD
No.
Qtr4
(2011-2015 aggregated)
Qtr4
(2016)
Significant change bet.
current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA0000000.000.00
HAEMOPHILUS INFLUENZA (INVASIVE).127246270.160.28
HEPATITIS A0..11.120.070.14
HEPATITIS B (ACUTE).175196180.200.28
INFLUENZA**114628675191377053.716.44X
MEASLES0009000.000.00
MUMPS0.00..0.010.05
PERTUSSIS.529897300.550.33
POLIOMYELITIS0000000.000.00
RUBELLA0000000.000.00
TETANUS0000000.000.00
SEXUALLY TRANSMITTED
CHLAMYDIA243210145261210089293811337112.89138.06X
GONORRHEA785276280129871002363231.2447.08X
HIV8229679314824293.343.85
SYPHILIS (EARLY LATENT)77308108401904453.384.23
SYPHILIS (PRIMARY & SECONDARY)63269852961123752.665.26X
Stage 3 HIV (AIDS)4220237166412072.251.93
ENTERICS
AMEBIASIS0..11.80.070.05
BOTULISM-INTESTINAL (INFANT)0000000.010.00
CAMPYLOBACTERIOSIS2010019101331211.031.55
CHOLERA0000000.000.00
CRYPTOSPORIDIOSIS0..6..0.040.05
GIARDIA144483112500.560.56
ROTAVIRUS653.6824540.191.13X
SALMONELLOSIS2611940176301482.441.41X
SHIGA-TOXIN PRODUCING E. COLI#.195359470.350.42
SHIGELLOSIS1028103110520.420.47
TYPHOID FEVER....0.0.030.00
VIBRIO (NON-CHOLERA)0.0.0.0.010.00
YERSINIOSIS..00..0.020.05
OTHER
ANTHRAX0000000.000.00
BOTULISM INTOXICATION0000000.000.00
BRUCELLOSIS00000.0.000.00
COCCIDIOIDOMYCOSIS15613910024751.121.13
DENGUE FEVER0.0.000.020.00
ENCEPHALITIS0.0.0.0.000.00
HANTAVIRUS0000000.000.00
HEMOLYTIC UREMIC SYNDROME (HUS)0.0.000.000.00
HEPATITIS C (ACUTE)0.07.220.030.19
HEPATITIS D0000000.000.00
INVASIVE GROUP A STREP.##0000000.000.00
LEGIONELLOSIS.21.21.240.120.14
LEPROSY (HANSEN’S DISEASE)0.00000.000.00
LEPTOSPIROSIS0000000.000.00
LISTERIOSIS0.0...0.010.05
LYME DISEASE0.050120.010.00
MALARIA.8.5.60.120.05
MENINGITIS, ASEPTIC/VIRAL941.3110290.370.47
MENINGITIS, BACTERIAL.12.15.310.100.05
MENINGOCOCCAL DISEASE..00.70.010.14
PLAGUE0000000.000.00
PSITTACOSIS00000.0.000.00
Q FEVER000.0.0.000.00
RABIES (HUMAN)0000000.000.00
RELAPSING FEVER0000000.000.00
ROCKY MOUNTAIN SPOTTED FEVER00000.0.000.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)20381656115952912008.3124.86X
STREPTOCOCCUS PNEUMONIAE, IPD###13772499431490.922.02X
TOXIC SHOCK SYN0000000.000.00
TOXIC SHOCK SYN (STREPTOCOCCAL).11715.180.140.14
TUBERCULOSIS106612718440.710.38
TULAREMIA0000000.000.00
UNUSUAL ILLNESS0000000.000.00
WEST NILE VIRUS (ENCEPHALITIS)0.0.0.0.000.00
WEST NILE VIRUS (FEVER)0000000.020.00
ZIKA VIRUS DISEASE, CONGENITAL~0000000.000.00
ZIKA VIRUS DISEASE, NON-CONGENITAL~00000160.000.00
ZIKA VIRUS INFECTION, CONGENITAL~0000000.000.00
ZIKA VIRUS INFECTION, NON-CONGENITAL~0000..0.000.05

 

*Due to software transition STD data since 2014 are not comparable with those in previous years. Rate denominators are interpolated population estimates/projections using demographic data under ongoing revisions by the state demographer. Use of onset date in data aggregation for cases other than STD or TB (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases that are reportable to CDC. HIV/AIDS/TB case counts provided by Office of Disease Surveillance. Data suppression denoted by ‘.’ applies if number of cases <5. Quarterly disease total (excluding STD and TB cases)=904(reported total=5177). Quarterly congenital syphilis cases (suppression applied) for 2014-2016 were .,.,.(YTD totals of .,6,9) respectively.
~Zika case definitions added in 2016.

~~Confidence intervals (not shown) for the quarterly disease incidence rates provided a basis for an informal statistical test to determine if the current quarterly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current quarter of this year or previous 5 years aggregated).

 

Updated on:  October 9, 2018

2018-10-09T16:22:50-07:00